期刊文献+

叶绿酸钠治疗老年肿瘤相关性贫血的临床回顾及分析 被引量:1

Clinical Review and Analysis of Sodium Chlorophyllin in the Treatment of Geriatric Oncology-related Anemia
原文传递
导出
摘要 目的分析叶绿酸钠治疗老年肿瘤相关性贫血的疗效及其意义。方法 2011年12月-2013年2月采集治疗背景相同的叶绿酸钠治疗(n=35)和无特殊治疗(n=36)老年肿瘤相关性贫血患者临床资料进行回顾,分析治疗前后贫血相关指标及生活质量评分的情况。结果叶绿酸钠组患者治疗后血红蛋白、红细胞计数,及生活质量评分较治疗前及无特殊治疗组均有所提高,差异有统计学意义(P<0.05)。结论叶绿酸钠能改善老年肿瘤相关性贫血患者的贫血状态,具有一定的研究推广价值。 Objective To analyze the clinical effect of sodium chlorophyllin in the treatment of geriatric oncology- related anemia and its significance. Methods We retrospectively analyzed the clinical data of elderly cancer patients with similar treatment background between December 2011 and February 2013, and the patients were divided into sodium chlorophyllin treatment group and no special treatment group. Then, parallel comparative study was carried out for anemia-related indexes and scores of quality of life. Results Hemoglobin, red blood cells and quality of life of sodium chlorophyllin treatment group were improved after treatment, and these indexes were also better than those in the no special treatment group (P 〈 0.05). Conclusion Sodium chlorophyllin can ameliorate anemia in elderly patients with oncology- related anemia, which is worthy of being popularized.
出处 《华西医学》 CAS 2014年第12期2220-2222,共3页 West China Medical Journal
基金 川北医学院苗圃科研基金项目(MP-ZK-13) 南充市科技局应用技术研究与开发资金项目(2010SF25) 四川省卫生厅科研课题(120426)~~
关键词 叶绿酸钠 肿瘤相关性贫血 老年 Sodium chlorophyllin Oncology-related anemia Elderly
  • 相关文献

参考文献15

  • 1Caro J J, Sa|as M, Ward A, et al. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, qualitative review[J]. Cancer, 2001, 91(12): 2214-2221.
  • 2Ludwig H, Strasser K. Symptomatology of anemia[J]. Semin Oncol, 2001, 28(2 Suppl 8): 7-14.
  • 3Tchekmedyian NS. Anemia in cancer patients: significance, epidemiology, and current therapy[J]. Ontology (WiUiston Park), 2002, 16(9 Suppl 10): 17-24.
  • 4Spivak JL. The anaemia of cancer: death by a thousand cuts[J]. Nat Rev Cancer, 2005, 5(7): 543-555.
  • 5Spivak JL. Iron and the anemia of chronic disease[J]. Ontology (Williston Park), 2002, 16(9 Suppl 10): 25-33.
  • 6Besarab A, H6rl WH, Silverberg D. Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome[J]. Oncologist, 2009, 14(Suppl 1): 22-33.
  • 7Streja E, Kovesdy CP, Greenland S, et al. Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis[J]. Am J Kidney Dis, 2008, 52(4): 727-736.
  • 8Ludwig H, Fritz E, Leitgeb C, et al. Prediction of response to erythropoietin treatment in chronic anemia of cancer[J]. Blood, 1994, 84(4): 1056-1063.
  • 9Leyland-Jones B, BEST investigators and Study Group. Breast cancer trial with erythro poietin terminated unexpcetedly[J]. Lancet Oncol, 2003, 4(8): 459.
  • 10Henke M, Laszig R, RObe C, et al. Erythropoietin to treat head and neek cancer patients with anaemiaun undergoing radiotherapy: randomised, double-blind, placebo-controlled trial[J]. Lancet, 2003, 362(9392): 1255-1260.

二级参考文献11

共引文献32

同被引文献15

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部